Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.
Angulo JC, Ciria Santos JP, Gómez-Caamaño A, Poza de Celis R, González Sala JL, García Garzón JM, Galán-Llopis JA, Pérez Sampietro M, Perrot V, Planas Morin J; ANARESISTANCE study group. Angulo JC, et al. World J Urol. 2022 Oct;40(10):2459-2466. doi: 10.1007/s00345-022-04108-x. Epub 2022 Sep 4. World J Urol. 2022. PMID: 36057895 Free PMC article.
Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.
Morote J, Tabernero ÁJ, Álvarez Ossorio JL, Ciria JP, Domínguez-Escrig JL, Vázquez F, Angulo J, López FJ, de La Iglesia R, Romero J; ANAMEM Investigator Group. Morote J, et al. Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):590-594. doi: 10.1016/j.ijrobp.2017.02.219. Epub 2017 Mar 6. Int J Radiat Oncol Biol Phys. 2017. PMID: 28581399
Cognitive function in patients on androgen suppression: A prospective, multicentric study.
Morote J, Tabernero ÁJ, Álvarez-Ossorio JL, Ciria JP, Domínguez-Escrig JL, Vázquez F, Angulo J, López FJ, de La Iglesia R, Romero J; Grupo de investigación ANAMEM. Morote J, et al. Among authors: tabernero aj. Actas Urol Esp (Engl Ed). 2018 Mar;42(2):114-120. doi: 10.1016/j.acuro.2017.04.007. Epub 2017 Nov 6. Actas Urol Esp (Engl Ed). 2018. PMID: 29102054 English, Spanish.
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study.
de la Piedra C, Alcaraz A, Bellmunt J, Meseguer C, Gómez-Caamano A, Ribal MJ, Vázquez F, Anido U, Samper P, Esteban E, Álvarez-Ossorio JL, Lara PC, San José LA, Contreras JA, del Alba AG, González-Gragera B, Tabernero AJ, González-Enguita C, Fernández JM, García-Escudero A, Gómez-Veiga F, Méndez MJ, Segarra J, Virizuela JA, Carles J, Lassa A, Calderero V, Constela M, Delgado D, Mañas A, Murias A, Reynes G, Rodriguez B, Rubio G, Sánchez E, Unda M, Solsona E, Martínez-Javaloyas JM, Comet-Batlle J, Quicios C, Martín-Fernández M, Mahillo-Fernández I, Morote J. de la Piedra C, et al. Among authors: tabernero aj. Br J Cancer. 2013 Jun 25;108(12):2565-72. doi: 10.1038/bjc.2013.270. Epub 2013 May 30. Br J Cancer. 2013. PMID: 23722472 Free PMC article. Clinical Trial.
Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml.
Martínez-Piñeiro L, García Mediero JM, González Gancedo P, Tabernero A, Lozano D, López-Tello JJ, Alonso-Dorrego JM, Núñez C, Picazo ML, Madero R, De La Peña JJ. Martínez-Piñeiro L, et al. Among authors: tabernero a. World J Urol. 2004 Jun;22(2):124-31. doi: 10.1007/s00345-003-0393-5. Epub 2004 Feb 20. World J Urol. 2004. PMID: 14986047
Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
Martínez-Piñeiro L, Tabernero A, Contreras T, Madero R, Lozano D, López-Tello J, Alonso-Dorrego JM, Picazo ML, González Gancedo P, Martínez-Piñeiro JA, de La Peña JJ. Martínez-Piñeiro L, et al. Among authors: tabernero a. Eur Urol. 2000 Mar;37(3):289-96. doi: 10.1159/000052358. Eur Urol. 2000. PMID: 10720854
Perinatal and childhood factors and risk of prostate cancer in adulthood: MCC-Spain case-control study.
Lope V, García-Esquinas E, Ruiz-Dominguez JM, LLorca J, Jiménez-Moleón JJ, Ruiz-Cerdá JL, Alguacil J, Tardón A, Dierssen-Sotos T, Tabernero Á, Mengual L, Kogevinas M, Aragonés N, Castaño-Vinyals G, Pollán M, Pérez-Gómez B. Lope V, et al. Among authors: tabernero a. Cancer Epidemiol. 2016 Aug;43:49-55. doi: 10.1016/j.canep.2016.06.012. Epub 2016 Jul 5. Cancer Epidemiol. 2016. PMID: 27391546
121 results